185:@0.890196:0.957873:0.914828:0.957873:0.914828:0.938882:0.890196:0.938882:0.007450:0.008591:0.008591
REFERENCES:@0.789358:0.066557:0.882352:0.066557:0.882352:0.045634:0.789358:0.045634:0.010295:0.008537:0.008058:0.008537:0.010295:0.008537:0.010706:0.010089:0.008398:0.009542
20.  Martínez-Jiménez, F. :@0.147059:0.119718:0.347289:0.119718:0.347289:0.101197:0.147059:0.101197:0.009483:0.009483:0.004088:0.003735:0.010563:0.017348:0.008259:0.007242:0.005852:0.005105:0.010542:0.008487:0.008031:0.006848:0.005601:0.005105:0.015898:0.008218:0.010542:0.008485:0.008031:0.004088:0.003466:0.007906:0.004088:0.003735
et al.:@0.347012:0.119718:0.381864:0.119718:0.381864:0.101006:0.347012:0.101006:0.007346:0.005727:0.003538:0.009048:0.004607:0.004586
 A compendium of mutational cancer driver genes. Nat. Rev. Can-:@0.381864:0.119718:0.882353:0.119718:0.882353:0.101197:0.381864:0.101197:0.003466:0.013572:0.003466:0.008176:0.009857:0.015709:0.010459:0.008218:0.010542:0.010355:0.004794:0.010376:0.016041:0.003466:0.009857:0.005644:0.003466:0.015709:0.010065:0.005956:0.008010:0.005852:0.005043:0.009857:0.010625:0.008550:0.004773:0.003466:0.008280:0.008259:0.010542:0.008176:0.008218:0.007097:0.003466:0.010355:0.007097:0.005041:0.008759:0.008218:0.007097:0.003466:0.008778:0.008218:0.010542:0.008218:0.006973:0.004088:0.003466:0.014132:0.008010:0.005852:0.004088:0.003466:0.012451:0.008487:0.007367:0.004088:0.003466:0.013613:0.008259:0.010647:0.006848
cer 20, 555–572 (2020).:@0.184412:0.140297:0.364432:0.140297:0.364432:0.121776:0.184412:0.121776:0.008176:0.008218:0.007097:0.003735:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
21.  Rahman, N. Realizing the promise of cancer predisposition genes. Nature 505, 302–308 :@0.147059:0.160875:0.886165:0.160875:0.886165:0.142355:0.147059:0.142355:0.009483:0.009483:0.004088:0.003735:0.010563:0.012638:0.008550:0.010417:0.015979:0.008259:0.010687:0.004088:0.006537:0.014754:0.004088:0.006537:0.012449:0.008446:0.008550:0.004773:0.005105:0.008031:0.005105:0.010417:0.008965:0.006537:0.006018:0.010272:0.008218:0.006526:0.010065:0.006765:0.009859:0.016041:0.005105:0.007157:0.008218:0.006537:0.009857:0.005644:0.006537:0.008280:0.008259:0.010542:0.008176:0.008218:0.007097:0.006537:0.010065:0.006765:0.008280:0.010355:0.005105:0.006827:0.010457:0.009961:0.006910:0.004794:0.005852:0.005043:0.009857:0.010687:0.006537:0.008778:0.008218:0.010542:0.008218:0.006973:0.004088:0.006537:0.014132:0.008010:0.005603:0.010376:0.006765:0.008218:0.006537:0.009483:0.009483:0.009483:0.004088:0.006526:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.003735
(2014).:@0.184412:0.181454:0.239051:0.181454:0.239051:0.162933:0.184412:0.162933:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
22.  Lane, D. P. p53, Guardian of the genome. Nature 358, 15–16 (1992).:@0.147059:0.202033:0.698759:0.202033:0.698759:0.183512:0.147059:0.183512:0.009483:0.009483:0.004088:0.003735:0.010563:0.010895:0.008259:0.010542:0.007948:0.004088:0.003735:0.013738:0.004088:0.003735:0.008010:0.004088:0.003735:0.010251:0.009483:0.009483:0.004088:0.003735:0.013881:0.010542:0.008259:0.006765:0.010355:0.005271:0.008259:0.010687:0.003735:0.009857:0.005644:0.003735:0.006018:0.010272:0.008218:0.003735:0.008778:0.008218:0.010542:0.009857:0.015896:0.007948:0.004088:0.003735:0.014132:0.008010:0.005603:0.010376:0.006765:0.008218:0.003735:0.009483:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.010729:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
23.  Holderfield, M., Deuker, M. M., McCormick, F. & McMahon, M. Targeting RAF kinases :@0.147059:0.222612:0.886128:0.222612:0.886128:0.204091:0.147059:0.204091:0.009483:0.009483:0.004088:0.003735:0.010563:0.014734:0.009940:0.004711:0.010293:0.008218:0.007097:0.005167:0.005105:0.008135:0.004711:0.010106:0.004088:0.006059:0.017826:0.004088:0.004088:0.006059:0.014754:0.008301:0.010500:0.009338:0.008218:0.005686:0.004088:0.006059:0.017826:0.004088:0.006059:0.017826:0.004088:0.004088:0.006059:0.017245:0.008176:0.013634:0.009857:0.007097:0.016041:0.005043:0.007969:0.009566:0.004088:0.006059:0.007906:0.004088:0.006059:0.014298:0.006059:0.017245:0.008176:0.017348:0.008550:0.010272:0.009857:0.010687:0.004088:0.006059:0.017826:0.004088:0.006059:0.009919:0.008259:0.006931:0.008778:0.008301:0.005852:0.005105:0.010417:0.008965:0.006059:0.012409:0.013572:0.010251:0.006059:0.009733:0.005105:0.010625:0.008446:0.007159:0.008218:0.006973:0.003735
for cancer therapy: BRAF-mutated melanoma and beyond. Nat. Rev. Cancer 14, 455–467 :@0.184412:0.243190:0.886148:0.243190:0.886148:0.224669:0.184412:0.224669:0.005478:0.009857:0.007097:0.005437:0.008278:0.008259:0.010544:0.008176:0.008218:0.007097:0.005437:0.006018:0.010272:0.008218:0.007180:0.008010:0.010085:0.009255:0.004088:0.005437:0.011330:0.012409:0.013572:0.009650:0.006848:0.015709:0.010065:0.005956:0.008010:0.005644:0.008280:0.010355:0.005437:0.015896:0.008135:0.004939:0.008259:0.010542:0.009857:0.015979:0.008446:0.005437:0.008259:0.010542:0.010355:0.005437:0.010231:0.008485:0.008656:0.009855:0.010544:0.010106:0.004088:0.005437:0.014132:0.008010:0.005852:0.004088:0.005437:0.012451:0.008487:0.007367:0.004088:0.005437:0.013613:0.008259:0.010542:0.008176:0.008218:0.007097:0.005437:0.009483:0.009483:0.004088:0.005437:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.003735
(2014).:@0.184412:0.263769:0.239051:0.263769:0.239051:0.245248:0.184412:0.245248:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
24.  Margulies, M. :@0.147059:0.284348:0.295661:0.284348:0.295661:0.265827:0.147059:0.265827:0.009483:0.009483:0.004088:0.003735:0.010563:0.017348:0.008259:0.006931:0.008965:0.010500:0.004773:0.005043:0.008218:0.006973:0.004088:0.004503:0.017826:0.004088:0.003735
et al.:@0.296426:0.284348:0.332347:0.284348:0.332347:0.265636:0.296426:0.265636:0.007346:0.005727:0.004607:0.009048:0.004607:0.004586
 Genome sequencing in microfabricated high-density picolitre reactors. :@0.332342:0.284348:0.886092:0.284348:0.886092:0.265827:0.332342:0.265827:0.004503:0.014381:0.008218:0.010542:0.009857:0.015896:0.008218:0.004503:0.007159:0.008280:0.009733:0.010314:0.008218:0.010542:0.008176:0.005105:0.010417:0.008965:0.004503:0.005105:0.010687:0.004503:0.016041:0.005043:0.008176:0.006765:0.009857:0.005644:0.008280:0.009836:0.007097:0.005043:0.008278:0.008010:0.005644:0.008280:0.010355:0.004503:0.010417:0.005105:0.009025:0.010417:0.006848:0.010293:0.008218:0.010563:0.006910:0.004794:0.005852:0.008840:0.004503:0.010065:0.005041:0.008176:0.009942:0.004773:0.004792:0.005852:0.006765:0.008218:0.004503:0.006765:0.008446:0.008446:0.008280:0.005644:0.009857:0.006931:0.006973:0.004088:0.003735
Nature 437, 376–380 (2005).:@0.184412:0.304926:0.403528:0.304926:0.403528:0.286406:0.184412:0.286406:0.014132:0.008010:0.005603:0.010376:0.006765:0.008218:0.003735:0.009483:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
25.  Valouev, A. :@0.147059:0.325505:0.274826:0.325505:0.274826:0.306984:0.147059:0.306984:0.009483:0.009483:0.004088:0.003735:0.010563:0.011704:0.008550:0.004711:0.009836:0.010314:0.008487:0.007367:0.004088:0.003964:0.013572:0.004088:0.003735
et al.:@0.275049:0.325505:0.310410:0.325505:0.310410:0.306793:0.275049:0.306793:0.007346:0.005727:0.004047:0.009048:0.004607:0.004586
 A high-resolution, nucleosome position map of C. elegans reveals a lack of :@0.310411:0.325505:0.886128:0.325505:0.886128:0.306984:0.310411:0.306984:0.003964:0.013572:0.003964:0.010417:0.005105:0.009027:0.010417:0.006848:0.006765:0.008218:0.007159:0.009940:0.004462:0.010065:0.005852:0.005043:0.009857:0.010687:0.004088:0.003964:0.010355:0.010316:0.007969:0.004711:0.008280:0.009959:0.007159:0.009857:0.015898:0.008218:0.003964:0.010459:0.009961:0.006910:0.004794:0.005852:0.005043:0.009857:0.010687:0.003964:0.015979:0.008012:0.010251:0.003964:0.009857:0.005644:0.003964:0.013343:0.004088:0.003964:0.008135:0.004711:0.008218:0.008965:0.008259:0.010563:0.006973:0.003964:0.006765:0.008487:0.008757:0.008446:0.008550:0.004773:0.006973:0.003964:0.008446:0.003964:0.004939:0.008446:0.007969:0.009566:0.003964:0.009857:0.005644:0.003735
universal sequence-dictated positioning. Genome Res. 18, 1051–1063 (2008).:@0.184412:0.346084:0.775621:0.346084:0.775621:0.327563:0.184412:0.327563:0.010376:0.010687:0.005043:0.008757:0.008218:0.006931:0.007222:0.008550:0.004773:0.003735:0.007159:0.008278:0.009733:0.010314:0.008218:0.010544:0.008176:0.008218:0.006848:0.010355:0.005041:0.008280:0.005956:0.008010:0.005644:0.008280:0.010355:0.003735:0.010459:0.009961:0.006910:0.004792:0.005852:0.005043:0.009857:0.010687:0.005105:0.010417:0.008799:0.004088:0.003735:0.014381:0.008218:0.010542:0.009857:0.015896:0.008218:0.003735:0.012451:0.008218:0.006973:0.004088:0.003735:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
26.  Bentley, D. R. :@0.147059:0.366663:0.292341:0.366663:0.292341:0.348142:0.147059:0.348142:0.009483:0.009483:0.004088:0.003735:0.010563:0.011891:0.008218:0.010355:0.006018:0.004711:0.008487:0.007263:0.004088:0.004399:0.013738:0.004088:0.004399:0.012451:0.004088:0.003735
et al.:@0.292996:0.366663:0.328813:0.366663:0.328813:0.347951:0.292996:0.347951:0.007346:0.005727:0.004503:0.009048:0.004607:0.004586
 Accurate whole human genome sequencing using reversible terminator :@0.328803:0.366663:0.886109:0.366663:0.886109:0.348142:0.328803:0.348142:0.004399:0.013032:0.008176:0.008280:0.010376:0.007180:0.008010:0.005644:0.008218:0.004399:0.013447:0.010272:0.009940:0.004711:0.008218:0.004399:0.010085:0.010376:0.015979:0.008259:0.010687:0.004399:0.008778:0.008218:0.010542:0.009857:0.015896:0.008218:0.004399:0.007159:0.008280:0.009733:0.010314:0.008218:0.010542:0.008176:0.005105:0.010417:0.008965:0.004399:0.010376:0.006910:0.005105:0.010417:0.008965:0.004399:0.006765:0.008487:0.008757:0.008218:0.006931:0.006910:0.005043:0.009919:0.004711:0.008218:0.004399:0.005644:0.008218:0.007097:0.016041:0.005105:0.010625:0.008010:0.005644:0.009857:0.007097:0.003735
chemistry. Nature 456, 53–59 (2008).:@0.184412:0.387241:0.467567:0.387241:0.467567:0.368720:0.184412:0.368720:0.007969:0.010272:0.008218:0.016041:0.005105:0.006827:0.005852:0.007637:0.007263:0.004088:0.003735:0.014132:0.008010:0.005603:0.010376:0.006765:0.008218:0.003735:0.009483:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.010729:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
27.  International Cancer Genome Consortium :@0.147059:0.407820:0.523813:0.407820:0.523813:0.389299:0.147059:0.389299:0.009483:0.009483:0.004088:0.003735:0.010563:0.006267:0.010355:0.005644:0.008218:0.007097:0.010625:0.008010:0.005852:0.005043:0.009857:0.010625:0.008550:0.004773:0.005458:0.013611:0.008259:0.010542:0.008176:0.008218:0.007097:0.005458:0.014381:0.008218:0.010542:0.009857:0.015896:0.008218:0.005447:0.013634:0.009857:0.010563:0.007159:0.009857:0.007242:0.005852:0.004794:0.010376:0.016041:0.003735
et al.:@0.525507:0.407820:0.562383:0.407820:0.562383:0.389108:0.525507:0.389108:0.007346:0.005727:0.005561:0.009048:0.004607:0.004586
 International network of cancer genome :@0.562390:0.407820:0.886105:0.407820:0.886105:0.389299:0.562390:0.389299:0.005447:0.006267:0.010355:0.005644:0.008218:0.007097:0.010625:0.008012:0.005852:0.005043:0.009857:0.010625:0.008548:0.004773:0.005458:0.010542:0.008301:0.005852:0.013198:0.009857:0.006910:0.009566:0.005447:0.009857:0.005644:0.005458:0.008280:0.008259:0.010542:0.008176:0.008218:0.007097:0.005447:0.008778:0.008218:0.010542:0.009857:0.015896:0.008218:0.003735
projects. Nature 464, 993–998 (2010).:@0.184412:0.428399:0.472255:0.428399:0.472255:0.409878:0.184412:0.409878:0.010065:0.006765:0.009836:0.004856:0.008280:0.008280:0.005852:0.006973:0.004088:0.003735:0.014130:0.008010:0.005603:0.010376:0.006765:0.008218:0.003735:0.009483:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
28.  Weinstein, J. N. :@0.147059:0.448977:0.304646:0.448977:0.304646:0.430456:0.147059:0.430456:0.009483:0.009483:0.004088:0.003735:0.010563:0.016954:0.008218:0.005105:0.010563:0.006827:0.005644:0.008218:0.005105:0.010687:0.004088:0.003528:0.005105:0.004088:0.003528:0.014754:0.004088:0.003735
et al.:@0.304458:0.448977:0.339383:0.448977:0.339383:0.430265:0.304458:0.430265:0.007346:0.005727:0.003611:0.009048:0.004607:0.004586
 The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, :@0.339385:0.448977:0.886022:0.448977:0.886022:0.430456:0.339385:0.430456:0.003528:0.010428:0.010282:0.008218:0.003528:0.013613:0.008259:0.010542:0.008176:0.008218:0.007097:0.003528:0.014381:0.008218:0.010542:0.009857:0.015896:0.008218:0.003528:0.012721:0.006018:0.004939:0.008446:0.006973:0.003528:0.010376:0.008259:0.010687:0.006848:0.013611:0.008259:0.010544:0.008176:0.008218:0.007097:0.003528:0.008259:0.010625:0.008550:0.004711:0.008840:0.006910:0.005105:0.006973:0.003528:0.010065:0.006765:0.009836:0.004856:0.008280:0.008278:0.005852:0.004088:0.003528:0.014132:0.008010:0.005852:0.004088:0.003528:0.014381:0.008218:0.010542:0.008301:0.005852:0.004088:0.003528:0.009483:0.009483:0.004088:0.003735
1113–1120 (2013).:@0.184412:0.469556:0.329383:0.469556:0.329383:0.451035:0.184412:0.451035:0.009483:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
29.  Priestley, P. :@0.147059:0.490135:0.274868:0.490135:0.274868:0.471614:0.147059:0.471614:0.009483:0.009483:0.004088:0.003735:0.010563:0.010832:0.007097:0.005043:0.008218:0.006827:0.006018:0.004711:0.008487:0.007263:0.004088:0.006039:0.008010:0.004088:0.003735
et al.:@0.277162:0.490135:0.314640:0.490135:0.314640:0.471423:0.277162:0.471423:0.007346:0.005727:0.006163:0.009048:0.004607:0.004586
 Pan-cancer whole-genome analyses of metastatic solid tumours. Nature :@0.314644:0.490135:0.886123:0.490135:0.886123:0.471614:0.314644:0.471614:0.006039:0.010376:0.008259:0.010687:0.006848:0.008280:0.008259:0.010542:0.008176:0.008218:0.007097:0.006039:0.013447:0.010272:0.009940:0.004711:0.008218:0.006848:0.008778:0.008218:0.010542:0.009857:0.015896:0.008218:0.006039:0.008259:0.010625:0.008550:0.004711:0.008840:0.007159:0.008218:0.006973:0.006039:0.009857:0.005644:0.006039:0.015896:0.008301:0.005956:0.008446:0.006827:0.005956:0.008010:0.005852:0.005043:0.008176:0.006039:0.007159:0.009940:0.004773:0.005043:0.010355:0.006039:0.005603:0.010376:0.015896:0.009836:0.010376:0.006931:0.006973:0.004088:0.006039:0.014130:0.008012:0.005603:0.010376:0.006765:0.008218:0.003735
575, 210–216 (2019).:@0.184412:0.510713:0.346689:0.510713:0.346689:0.492193:0.184412:0.492193:0.009483:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
30.  Gröbner, S. N. :@0.147059:0.531292:0.298566:0.531292:0.298566:0.512771:0.147059:0.512771:0.009483:0.009483:0.004088:0.003735:0.010563:0.014070:0.006765:0.009961:0.009836:0.010542:0.008218:0.005686:0.004088:0.004565:0.009193:0.004088:0.004565:0.014754:0.004088:0.003735
et al.:@0.299412:0.531292:0.335396:0.531292:0.335396:0.512580:0.299412:0.512580:0.007346:0.005727:0.004669:0.009048:0.004607:0.004586
 Author Correction: The landscape of genomic alterations across child-:@0.335398:0.531292:0.882353:0.531292:0.882353:0.512771:0.335398:0.512771:0.004565:0.012721:0.010065:0.006018:0.010272:0.009857:0.007097:0.004565:0.013634:0.009857:0.007097:0.006765:0.008280:0.008280:0.005852:0.005043:0.009857:0.010687:0.004088:0.004565:0.010428:0.010282:0.008218:0.004565:0.004939:0.008259:0.010542:0.010355:0.007159:0.008280:0.008010:0.010459:0.008218:0.004565:0.009859:0.005644:0.004565:0.008778:0.008218:0.010542:0.009857:0.016041:0.005043:0.008176:0.004565:0.008550:0.004462:0.005644:0.008218:0.007180:0.008010:0.005852:0.005043:0.009857:0.010563:0.006973:0.004565:0.008446:0.008176:0.006765:0.009961:0.006848:0.006973:0.004565:0.007969:0.010417:0.005229:0.004711:0.010399:0.006848
hood cancers. Nature 559, E10 (2018).:@0.184412:0.551871:0.475930:0.551871:0.475930:0.533350:0.184412:0.533350:0.010272:0.010251:0.010251:0.010355:0.003735:0.008280:0.008259:0.010542:0.008176:0.008218:0.006931:0.006973:0.004088:0.003735:0.014132:0.008010:0.005603:0.010376:0.006765:0.008218:0.003735:0.009483:0.009483:0.009483:0.004088:0.003735:0.010998:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
31.  Ma, X. :@0.147059:0.572450:0.239051:0.572450:0.239051:0.553929:0.147059:0.553929:0.009483:0.009483:0.004088:0.003735:0.010563:0.017348:0.008446:0.004088:0.004109:0.012825:0.004088:0.003735
et al.:@0.239427:0.572450:0.274943:0.572450:0.274943:0.553738:0.239427:0.553738:0.007346:0.005727:0.004202:0.009048:0.004607:0.004586
 Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias :@0.274942:0.572450:0.886077:0.572450:0.886077:0.553929:0.274942:0.553929:0.004109:0.010376:0.008259:0.010687:0.006848:0.008280:0.008259:0.010542:0.008176:0.008218:0.007097:0.004109:0.008778:0.008218:0.010542:0.009859:0.015896:0.008218:0.004109:0.008259:0.010544:0.010355:0.004109:0.005852:0.007180:0.008259:0.010563:0.007159:0.008176:0.007097:0.004794:0.010044:0.005644:0.009857:0.015896:0.008218:0.004109:0.008259:0.010625:0.008550:0.004711:0.008840:0.007157:0.008218:0.006973:0.004109:0.009857:0.005644:0.004109:0.009483:0.004088:0.009483:0.009483:0.009483:0.004109:0.010334:0.008446:0.008280:0.010355:0.005269:0.008010:0.005852:0.007097:0.005043:0.008176:0.004109:0.004711:0.008301:0.010500:0.009650:0.008446:0.008218:0.016041:0.005271:0.008446:0.006973:0.003735
and solid tumours. Nature 555, 371–376 (2018).:@0.184412:0.593028:0.551238:0.593028:0.551238:0.574507:0.184412:0.574507:0.008259:0.010542:0.010355:0.003735:0.007159:0.009940:0.004773:0.005043:0.010355:0.003735:0.005603:0.010376:0.015896:0.009836:0.010376:0.006931:0.006973:0.004088:0.003735:0.014132:0.008010:0.005603:0.010376:0.006765:0.008218:0.003735:0.009483:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
32.  Wong, M. :@0.147059:0.613607:0.263289:0.613607:0.263289:0.595086:0.147059:0.595086:0.009483:0.009483:0.004088:0.003735:0.010563:0.016954:0.009857:0.010417:0.008799:0.004088:0.003113:0.017826:0.004088:0.003735
et al.:@0.262680:0.613607:0.297190:0.613607:0.297190:0.594895:0.262680:0.594895:0.007346:0.005727:0.003196:0.009048:0.004607:0.004586
 Whole genome, transcriptome and methylome profiling enhances actionable :@0.297183:0.613607:0.886033:0.613607:0.886033:0.595086:0.297183:0.595086:0.003113:0.018822:0.010274:0.009940:0.004711:0.008218:0.003113:0.008778:0.008218:0.010542:0.009857:0.015896:0.007948:0.004088:0.003113:0.005852:0.007180:0.008259:0.010563:0.007159:0.008176:0.007097:0.004792:0.010044:0.005647:0.009857:0.015896:0.008218:0.003113:0.008259:0.010542:0.010355:0.003113:0.015898:0.008299:0.006018:0.010065:0.008902:0.004711:0.009857:0.015896:0.008218:0.003113:0.010065:0.006765:0.009857:0.005167:0.005292:0.004773:0.005105:0.010417:0.008965:0.003113:0.008218:0.010791:0.010355:0.008259:0.010542:0.008176:0.008218:0.006973:0.003113:0.008446:0.008280:0.005852:0.005043:0.009857:0.010627:0.008278:0.009919:0.004711:0.008218:0.003735
target discovery in high-risk pediatric cancer. Nat. Med. (2020) doi:10.1038/s41591-020-:@0.184412:0.634186:0.882358:0.634186:0.882358:0.615665:0.184412:0.615665:0.005956:0.008259:0.006931:0.008778:0.008301:0.005852:0.006225:0.010355:0.005105:0.007157:0.008176:0.009878:0.008757:0.008218:0.007637:0.008840:0.006225:0.005105:0.010687:0.006225:0.010417:0.005105:0.009025:0.010417:0.006848:0.007097:0.005105:0.006869:0.009566:0.006225:0.010459:0.008280:0.010355:0.005269:0.008010:0.005852:0.007097:0.005043:0.008176:0.006225:0.008280:0.008259:0.010542:0.008176:0.008218:0.005686:0.004088:0.006225:0.014132:0.008010:0.005852:0.004088:0.006225:0.017245:0.008280:0.010106:0.004088:0.006225:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.006239:0.010293:0.009857:0.005105:0.004088:0.009483:0.009483:0.004088:0.009483:0.009483:0.009483:0.009483:0.006454:0.006973:0.009483:0.009483:0.009483:0.009483:0.009483:0.006848:0.009483:0.009483:0.009483:0.006848
1072-4.:@0.184412:0.654764:0.242763:0.654764:0.242763:0.636244:0.184412:0.636244:0.009483:0.009483:0.009483:0.009483:0.006848:0.009482:0.004088
33.  Vis, D. J. :@0.147059:0.675343:0.253598:0.675343:0.253598:0.656822:0.147059:0.656822:0.009483:0.009483:0.004088:0.003735:0.010563:0.012762:0.005105:0.006973:0.004088:0.004752:0.013738:0.004088:0.004752:0.005105:0.004088:0.003735
et al.:@0.254615:0.675343:0.290785:0.675343:0.290785:0.656631:0.254615:0.656631:0.007346:0.005727:0.004856:0.009048:0.004607:0.004586
 Towards a global cancer knowledge network: dissecting the current interna-:@0.290786:0.675343:0.882353:0.675343:0.882353:0.656822:0.290786:0.656822:0.004752:0.009878:0.009878:0.013385:0.008259:0.006765:0.010355:0.006973:0.004752:0.008446:0.004752:0.009027:0.004711:0.009961:0.010106:0.008550:0.004773:0.004752:0.008280:0.008259:0.010542:0.008176:0.008218:0.007097:0.004752:0.009733:0.010544:0.009878:0.013445:0.004711:0.008280:0.010355:0.008778:0.008218:0.004752:0.010542:0.008301:0.005852:0.013198:0.009857:0.006912:0.009566:0.004088:0.004752:0.010355:0.005105:0.006848:0.007157:0.008280:0.008280:0.005852:0.005105:0.010417:0.008965:0.004752:0.006018:0.010272:0.008218:0.004752:0.008278:0.010376:0.007097:0.006765:0.008218:0.010355:0.005852:0.004752:0.005105:0.010355:0.005647:0.008218:0.007097:0.010625:0.008446:0.006848
tional cancer genomic sequencing landscape. Ann. Oncol. 28, 1145–1151 (2017).:@0.184412:0.695922:0.802310:0.695922:0.802310:0.677401:0.184412:0.677401:0.005852:0.005043:0.009857:0.010625:0.008550:0.004773:0.003735:0.008280:0.008259:0.010542:0.008176:0.008218:0.007097:0.003735:0.008778:0.008218:0.010542:0.009857:0.016041:0.005043:0.008176:0.003735:0.007159:0.008280:0.009730:0.010314:0.008218:0.010544:0.008176:0.005105:0.010417:0.008965:0.003735:0.004937:0.008259:0.010544:0.010355:0.007157:0.008280:0.008010:0.010459:0.007948:0.004088:0.003735:0.013572:0.010687:0.010687:0.004088:0.003735:0.014817:0.010542:0.008176:0.009940:0.004524:0.004088:0.003735:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
34.  Hyman, D. M., Taylor, B. S. & Baselga, J. Implementing Genome-Driven Oncology. Cell 168, :@0.147059:0.716500:0.886169:0.716500:0.886169:0.697980:0.147059:0.697980:0.009483:0.009483:0.004088:0.003735:0.010563:0.014609:0.008840:0.015979:0.008259:0.010687:0.004088:0.003507:0.013738:0.004088:0.003507:0.017826:0.004088:0.004088:0.003507:0.009919:0.008114:0.008902:0.004711:0.009857:0.005686:0.004088:0.003507:0.010957:0.004088:0.003507:0.009193:0.004088:0.003507:0.014298:0.003507:0.011704:0.008446:0.007159:0.008135:0.004773:0.008965:0.008446:0.004088:0.003507:0.005105:0.004088:0.003507:0.006267:0.015709:0.010148:0.004711:0.008218:0.015896:0.008218:0.010355:0.005852:0.005105:0.010417:0.008965:0.003507:0.014381:0.008218:0.010542:0.009857:0.015896:0.008218:0.006848:0.014568:0.007097:0.005043:0.008757:0.008218:0.010687:0.003507:0.014819:0.010542:0.008176:0.009940:0.004711:0.010044:0.009585:0.007265:0.004088:0.003507:0.013632:0.008135:0.004897:0.004773:0.003507:0.009483:0.009483:0.009483:0.004088:0.003735
584–599 (2017).:@0.184412:0.737079:0.310415:0.737079:0.310415:0.718558:0.184412:0.718558:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
35.  Berger, M. F. & Mardis, E. R. The emerging clinical relevance of genomics in cancer medicine. :@0.147059:0.757658:0.886111:0.757658:0.886111:0.739137:0.147059:0.739137:0.009483:0.009483:0.004088:0.003735:0.010563:0.011891:0.008218:0.006931:0.008778:0.008218:0.005686:0.004088:0.003030:0.017826:0.004088:0.003030:0.007908:0.004088:0.003030:0.014298:0.003030:0.017348:0.008261:0.006765:0.010355:0.005105:0.006973:0.004088:0.003030:0.010998:0.004088:0.003030:0.012451:0.004088:0.003030:0.010428:0.010282:0.008218:0.003030:0.008218:0.015896:0.008218:0.006931:0.008965:0.005105:0.010417:0.008965:0.003030:0.007969:0.004773:0.005105:0.010687:0.005043:0.008280:0.008550:0.004773:0.003030:0.006765:0.008135:0.004711:0.008487:0.008944:0.008259:0.010542:0.008176:0.008218:0.003030:0.009857:0.005644:0.003030:0.008778:0.008218:0.010542:0.009857:0.016041:0.005043:0.008176:0.006973:0.003030:0.005105:0.010687:0.003030:0.008280:0.008259:0.010542:0.008176:0.008218:0.007097:0.003030:0.015898:0.008278:0.010355:0.005043:0.008176:0.005105:0.010542:0.007948:0.004088:0.003735
Nat. Rev. Clin. Oncol. 15, 353–365 (2018).:@0.184412:0.778237:0.506765:0.778237:0.506765:0.759716:0.184412:0.759716:0.014132:0.008010:0.005852:0.004088:0.003735:0.012451:0.008487:0.007367:0.004088:0.003735:0.013403:0.004773:0.005105:0.010687:0.004088:0.003735:0.014817:0.010542:0.008176:0.009940:0.004524:0.004088:0.003735:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
36.  Nangalia, J. & Campbell, P. J. Genome Sequencing during a Patient’s Journey through Cancer. :@0.147059:0.798815:0.886090:0.798815:0.886090:0.780294:0.147059:0.780294:0.009483:0.009483:0.004088:0.003735:0.010563:0.014132:0.008259:0.010417:0.008965:0.008550:0.004773:0.005271:0.008446:0.004088:0.003082:0.005105:0.004088:0.003080:0.014298:0.003082:0.013613:0.008259:0.015709:0.010168:0.010231:0.008135:0.004897:0.004524:0.004088:0.003082:0.008010:0.004088:0.003082:0.005103:0.004088:0.003082:0.014381:0.008218:0.010542:0.009857:0.015898:0.008218:0.003080:0.009629:0.008280:0.009733:0.010314:0.008218:0.010542:0.008176:0.005105:0.010417:0.008965:0.003082:0.010044:0.010376:0.007097:0.005105:0.010417:0.008965:0.003082:0.008446:0.003082:0.010376:0.008010:0.005852:0.005043:0.008218:0.010355:0.004958:0.001577:0.006973:0.003082:0.005665:0.009836:0.010376:0.007097:0.010542:0.008487:0.008840:0.003082:0.006018:0.010417:0.006765:0.009836:0.010376:0.009027:0.010417:0.003082:0.013613:0.008259:0.010542:0.008176:0.008218:0.005686:0.004088:0.003735
New England Journal of Medicine 381, 2145–2156 (2019).:@0.184412:0.819394:0.630237:0.819394:0.630237:0.800873:0.184412:0.800873:0.014111:0.008487:0.013385:0.003735:0.010998:0.010417:0.009027:0.004939:0.008259:0.010542:0.010355:0.003735:0.005665:0.009836:0.010376:0.007097:0.010625:0.008550:0.004773:0.003735:0.009855:0.005644:0.003735:0.017245:0.008280:0.010355:0.005043:0.008176:0.005105:0.010542:0.008218:0.003735:0.009483:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
37.  Druker, B. J. :@0.147059:0.839973:0.280658:0.839973:0.280658:0.821452:0.147059:0.821452:0.009483:0.009483:0.004088:0.003735:0.010563:0.014568:0.007242:0.010500:0.009338:0.008218:0.005686:0.004088:0.004316:0.010957:0.004088:0.004316:0.005105:0.004088:0.003735
et al.:@0.281214:0.839973:0.316927:0.839973:0.316927:0.821261:0.281214:0.821261:0.007346:0.005727:0.004399:0.009048:0.004607:0.004586
 Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase :@0.316931:0.839973:0.886188:0.839973:0.886188:0.821452:0.316931:0.821452:0.004316:0.010998:0.005174:0.005174:0.005112:0.008280:0.008446:0.008529:0.008840:0.004316:0.008259:0.010542:0.010355:0.004316:0.007222:0.008259:0.005478:0.008301:0.005852:0.008840:0.004316:0.009857:0.005644:0.004316:0.008446:0.004316:0.006827:0.010459:0.008280:0.008176:0.005105:0.005167:0.005105:0.008176:0.004316:0.005105:0.010791:0.010417:0.005043:0.009836:0.004792:0.005647:0.009857:0.007097:0.004316:0.009857:0.005644:0.004316:0.006018:0.010272:0.008218:0.004316:0.011870:0.013343:0.011227:0.006848:0.013572:0.011328:0.010563:0.004316:0.005852:0.008840:0.006765:0.009961:0.006910:0.005105:0.010542:0.008218:0.004316:0.009733:0.005105:0.010625:0.008446:0.007159:0.008218:0.003735
in chronic myeloid leukemia. N. Engl. J. Med. 344, 1031–1037 (2001).:@0.184412:0.860551:0.714406:0.860551:0.714406:0.842031:0.184412:0.842031:0.005105:0.010687:0.003735:0.007969:0.010417:0.006765:0.009857:0.010687:0.005043:0.008176:0.003735:0.015688:0.008653:0.008135:0.004711:0.009857:0.005043:0.010355:0.003735:0.004711:0.008301:0.010500:0.009338:0.008218:0.016041:0.005269:0.008446:0.004088:0.003735:0.014754:0.004088:0.003735:0.010998:0.010417:0.009027:0.004524:0.004088:0.003735:0.005105:0.004088:0.003735:0.017245:0.008280:0.010106:0.004088:0.003735:0.009483:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
38.  Shaw, A. T. :@0.147059:0.881130:0.270738:0.881130:0.270738:0.862609:0.147059:0.862609:0.009483:0.009483:0.004088:0.003735:0.010563:0.008923:0.010355:0.008114:0.011808:0.004088:0.003798:0.013572:0.004088:0.003798:0.009961:0.004088:0.003735
et al.:@0.270802:0.881130:0.305998:0.881130:0.305998:0.862418:0.270802:0.862418:0.007346:0.005727:0.003881:0.009050:0.004607:0.004586
 Crizotinib in ROS1-rearranged non-small-cell lung cancer. N. Engl. J. Med. :@0.305997:0.881130:0.886086:0.881130:0.886086:0.862609:0.305997:0.862609:0.003798:0.013281:0.007097:0.005105:0.008031:0.009836:0.005852:0.005105:0.010687:0.005043:0.010023:0.003798:0.005105:0.010687:0.003798:0.012098:0.014920:0.009193:0.009483:0.006848:0.006763:0.008446:0.008259:0.007097:0.007180:0.008259:0.010417:0.008778:0.008280:0.010355:0.003798:0.010544:0.009857:0.010687:0.006848:0.006910:0.015979:0.008548:0.004897:0.004773:0.006848:0.008176:0.008135:0.004897:0.004773:0.003798:0.004462:0.010376:0.010417:0.008965:0.003798:0.008280:0.008259:0.010542:0.008176:0.008218:0.005686:0.004088:0.003798:0.014754:0.004088:0.003798:0.010998:0.010419:0.009025:0.004524:0.004088:0.003798:0.005105:0.004088:0.003798:0.017245:0.008280:0.010106:0.004088:0.003735
371, 1963–1971 (2014).:@0.184412:0.901709:0.365656:0.901709:0.365656:0.883188:0.184412:0.883188:0.009483:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088